Ovarian cancer is the fifth leading cause of cancer incidence and the most common cause of death from gynecological malignancies in the Western World (1). The asymptomatic onset and insidious ...

ORLANDO, Fla. — Patients treated with combined hemodialysis and peritoneal dialysis from the start of renal replacement therapy showed advantages over patients who used a single therapy only, ...

Kidney disease impacts millions globally. Two main treatments, hemodialysis and peritoneal dialysis, offer life-saving ...

Intratumoral Ral-binding protein 1 (RalBP1) expression as a potential predictor of bevacizumab treatment efficacy in patients with ovarian cancer. This is an ASCO Meeting Abstract from the 2024 ASCO ...

Main driver genes and BRCA mutation in Chinese patients with pancreatic adenocarcinoma. Nab-paclitaxel/S-1(AS) versus nab-paclitaxel/gemcitabine(AG) for first-line ...

The FDA has approved orphan drug designation for a new supplemental dialysate solution for patients on peritoneal dialysis. Zytoprotec, a biopharmaceutical company based in Vienna, Austria, said the ...

CUTTACK: Unavailability of continuous ambulatory peritoneal dialysis (CAPD) fluid, essential for dialysis procedure, at SCB ...

Fox Chase Cancer Center researchers have found a new way to detect ovarian cancer in the blood. Reported in the Sept. 15, 2004, issue of Cancer Research, the new method targets hypermethylation--one ...

For permission requests, please contact NEJM Reprints at [email protected] The patients were 4 adult females, twenty to forty years old, admitted to the Los Angeles County Hospital with acute ...

Morison’s pouch is an area between your liver and your right kidney. It’s also called the hepatorenal recess or right subhepatic space. Morison’s pouch is a potential space that can open up when fluid ...